Protective effects of the RAGE inhibitor azeliragon as a potential anti-Streptococcus pneumoniae therapeutic in sepsis models
The increasing antimicrobial resistance of Streptococcus pneumoniae (S. pneumoniae) presents a major therapeutic challenge and underscores the need for agents with novel mechanisms of action. Azeliragon is a small-molecule inhibitor of the receptor for advanced glycation end products (RAGE), but its...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2026-04-01
|
| Saila: | Frontiers in Medicine |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1793580/full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|